-
Mashup Score: 4Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 1Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Latest Headlines, NeurologyTweet-
After a rocky course, #AMX3500 got the @US_FDA nod for #AmyotrophicLateralSclerosis this week. How much it will cost and will Medicare pay for it? Questions remain. https://t.co/9Ipr28eIHn @PaganoniMDPhD @JinsyMd and other @AANmember comment. #Neurotwitter #Neurology https://t.co/mYg9C3Tdwu
-
-
Mashup Score: 0Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Latest Headlines, NeurologyTweet-
Via @AANEMorg annual meeting: Patients sent to academic medical centers for #AmyotrophicLateralSclerosis evaluation didn’t benefit from autoantibody tests: https://t.co/2rdGcinCWO #neurology #neurotwitter #NeurologyToday #ALS @AANmember @EmoryMedicine @EleanorT84 https://t.co/44ROMbgZ2g
-
-
Mashup Score: 5Longer-Term Use of Investigational Drug Stabilizes ALS Symptoms - 2 year(s) ago
The use of the drug tofersen for one year may help stabilize muscle strength and motor control in patients with an inherited form of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease. The results are part of an open-label extension of a Phase III clinical trial sponsored by the pharmaceutical company Biogen.
Categories: Future of Medicine, Latest HeadlinesTweet-
Investigators have shown that the use of the drug tofersen for one year may help stabilize muscle strength and motor control in patients with an inherited form of #amyotrophiclateralsclerosis (#ALS). Learn more: https://t.co/oDZrh1ZgD1 https://t.co/4AOsXWy7nE
-
-
Mashup Score: 5Longer-Term Use of Investigational Drug Stabilizes ALS Symptoms - 2 year(s) ago
The use of the drug tofersen for one year may help stabilize muscle strength and motor control in patients with an inherited form of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease. The results are part of an open-label extension of a Phase III clinical trial sponsored by the pharmaceutical company Biogen.
Categories: Future of Medicine, Latest HeadlinesTweet-
Investigators have shown that the use of the drug tofersen for one year may help stabilize muscle strength and motor control in patients with an inherited form of #amyotrophiclateralsclerosis (#ALS). Learn more: https://t.co/oDZrh1ZgD1 https://t.co/wbnhVILccq
-
-
Mashup Score: 11Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Latest Headlines, NeurologyTweet-
The @FDA and @NIH have launched a new public-private partnership to expedite the development of therapies for rare #neurogenerative diseases, such as #AmyotrophicLateralSclerosis: https://t.co/BcRcoI3jgu #ALS #neurology #neurotwitter @AANMember https://t.co/CCd99nVUJv
-
-
Mashup Score: 2
Researchers are now initiating a feasibility study investigating the effects of terazosin in patients with motor neuron disease.
Categories: Future of Medicine, Latest HeadlinesTweet-
Scientists at @EdinburghUni and @UniofOxford have found that a drug typically used to treat enlarged prostates and high blood pressure could also have promise as a potential new therapy for #amyotrophiclateralsclerosis. Learn more: https://t.co/L8oYHHAiQc https://t.co/jNNb1nDlPT
-
-
Mashup Score: 7
Potential therapeutic targets for amyotrophic lateral sclerosis identified using an artificial intelligence-powered target discovery engine.
Categories: Future of Medicine, Latest HeadlinesTweet-
Potential therapeutic targets for #amyotrophiclateralsclerosis identified using an #artificialintelligence powered target discovery engine. Learn more: https://t.co/MxplRZosXB https://t.co/VKjpsCizMf
-
-
Mashup Score: 1
Potential therapeutic targets for amyotrophic lateral sclerosis identified using an artificial intelligence-powered target discovery engine.
Categories: Future of Medicine, Latest HeadlinesTweet-
Potential therapeutic targets for #amyotrophiclateralsclerosis identified using an #artificialintelligence powered target discovery engine. Learn more: https://t.co/MxplRZosXB https://t.co/9OFpiaZ02W
-
-
Mashup Score: 0
Potential therapeutic targets for amyotrophic lateral sclerosis identified using an artificial intelligence-powered target discovery engine.
Categories: Future of Medicine, Latest HeadlinesTweet-
#AI Finds Potential Drug Targets for #AmyotrophicLateralSclerosis Potential therapeutic targets for amyotrophic lateral sclerosis identified using an artificial intelligence-powered target discovery engine. Learn more: https://t.co/MxplRZosXB https://t.co/yQA6UOnHAi
-
.@icer_review gives lackluster evaluation to AMX0035 and the oral formulation of edaravone, both emerging treatments for #AmyotrophicLateralSclerosis: https://t.co/fd1V6D96uC #ALS #neurotwitter #neurology @AANmember @JinsyMd @PaganoniMDPhD @DukeMedSchool https://t.co/IZkR9f4cZW